Melinda Davis, PA
Physician Assistant · Stratford, CTNPI 1215346390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 528 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 528 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$1K
- Amgen$813
- AstraZeneca$647
- Boehringer Ingelheim$559
- Exact Sciences$530
- plus $5K from 32 others
What the payments were for
- Food & beverage$10,24499%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 106 | $1,923 |
| GSK | 61 | $1,091 |
| Amgen | 43 | $813 |
| AstraZeneca | 38 | $647 |
| Boehringer Ingelheim | 25 | $559 |
| Exact Sciences | 20 | $530 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $494 |
| Lilly USA, LLC | 25 | $442 |
| Merck | 22 | $420 |
| Pfizer | 19 | $376 |
| Novo Nordisk | 18 | $373 |
| Johnson & Johnson | 19 | $357 |
| Lundbeck LLC | 14 | $290 |
| Esperion Therapeutics, Inc. | 10 | $260 |
| Teva Pharmaceuticals USA, Inc. | 10 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $182 |
| Astellas Pharma US Inc | 9 | $176 |
| Ironwood Pharmaceuticals, Inc | 7 | $141 |
| Amarin Pharma, Inc. | 5 | $107 |
| Amneal Pharmaceuticals LLC | 5 | $103 |
| Actelion Pharmaceuticals US, Inc. | 3 | $97 |
| E.r. Squibb & Sons, L.L.C. | 5 | $96 |
| Bayer | 4 | $93 |
| Idorsia Pharmaceuticals US Inc | 4 | $75 |
| Eisai Inc. | 5 | $73 |
| Baxter Healthcare | 2 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Abbott | 2 | $47 |
| Novartis | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Intra-sana Laboratories | 1 | $20 |
| Medtronic | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Vistapharm, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$10,342 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $46,878 |
| EliquisApixaban | 21 | $26,003 |
| OzempicSemaglutide | 16 | $23,241 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $18,348 |
| FarxigaDapagliflozin Propanediol | 11 | $15,850 |
| SynthroidLevothyroxine Sodium | 29 | $2,673 |
| Atorvastatin Calcium | 184 | $1,603 |
| Rosuvastatin Calcium | 118 | $1,480 |
| Levothyroxine Sodium | 106 | $1,346 |
| Gabapentin | 35 | $1,154 |
| Nebivolol Hcl | 17 | $840 |
| Omeprazole | 42 | $762 |
| Celecoxib | 34 | $546 |
| Pantoprazole Sodium | 26 | $538 |
| Losartan Potassium | 53 | $515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $376 | $26,00321 claims |
| Novo NordiskOzempic | $373 | $23,24116 claims |
| GSKTrelegy Ellipta | $1,091 | $18,34815 claims |
| AstraZenecaFarxiga | $647 | $15,85011 claims |
| AbbVieSynthroid | $1,923 | $2,67329 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $103 | $1,346106 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $18026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,795 physician assistant providers in Connecticut.
Other physician assistant in Stratford
- Alexandra MarquesStratford$14K
- Gary SpinnerBridgeport$119K
- Jordan MarcouTrumbull$44K
- Mary ElliottGuilford$43K
- Christopher ThompsonGroton$42K
- Michael LalondeNew Haven$35K
- Kristine LaneMiddletown$30K
- Kathryn MidgleyNew Haven$28K
- Richard MoroPlainfield$25K
- Janine TedescoDarien$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.